Update in Management of Severe Hypoxemic Respiratory Failure. 2017

Dharani Kumari Narendra, and Dean R Hess, and Curtis N Sessler, and Habtamu M Belete, and Kalpalatha K Guntupalli, and Felix Khusid, and Charles Mark Carpati, and Mark Elton Astiz, and Suhail Raoof
Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX.

Mortality related to severe-moderate and severe ARDS remains high. We searched the literature to update this topic. We defined severe hypoxemic respiratory failure as Pao2/Fio2 < 150 mm Hg (ie, severe-moderate and severe ARDS). For these patients, we support setting the ventilator to a tidal volume of 4 to 8 mL/kg predicted body weight (PBW), with plateau pressure (Pplat) ≤ 30 cm H2O, and initial positive end-expiratory pressure (PEEP) of 10 to 12 cm H2O. To promote alveolar recruitment, we propose increasing PEEP in increments of 2 to 3 cm provided that Pplat remains ≤ 30 cm H2O and driving pressure does not increase. A fluid-restricted strategy is recommended, and nonrespiratory causes of hypoxemia should be considered. For patients who remain hypoxemic after PEEP optimization, neuromuscular blockade and prone positioning should be considered. Profound refractory hypoxemia (Pao2/Fio2 < 80 mm Hg) after PEEP titration is an indication to consider extracorporeal life support. This may necessitate early transfer to a center with expertise in these techniques. Inhaled vasodilators and nontraditional ventilator modes may improve oxygenation, but evidence for improved outcomes is weak.

UI MeSH Term Description Entries
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D012131 Respiratory Insufficiency Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed) Acute Hypercapnic Respiratory Failure,Acute Hypoxemic Respiratory Failure,Hypercapnic Acute Respiratory Failure,Hypercapnic Respiratory Failure,Hypoxemic Acute Respiratory Failure,Hypoxemic Respiratory Failure,Respiratory Depression,Respiratory Failure,Ventilatory Depression,Depressions, Ventilatory,Failure, Hypercapnic Respiratory,Failure, Hypoxemic Respiratory,Failure, Respiratory,Hypercapnic Respiratory Failures,Hypoxemic Respiratory Failures,Respiratory Failure, Hypercapnic,Respiratory Failure, Hypoxemic,Respiratory Failures
D005440 Fluid Therapy Therapy whose basic objective is to restore the volume and composition of the body fluids to normal with respect to WATER-ELECTROLYTE BALANCE. Fluids may be administered intravenously, orally, by intermittent gavage, or by HYPODERMOCLYSIS. Oral Rehydration Therapy,Rehydration,Rehydration, Oral,Oral Rehydration,Rehydration Therapy, Oral,Therapy, Fluid,Therapy, Oral Rehydration,Fluid Therapies,Oral Rehydration Therapies,Oral Rehydrations,Rehydration Therapies, Oral,Rehydrations,Rehydrations, Oral,Therapies, Fluid,Therapies, Oral Rehydration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D013990 Tidal Volume The volume of air inspired or expired during each normal, quiet respiratory cycle. Common abbreviations are TV or V with subscript T. Tidal Volumes,Volume, Tidal,Volumes, Tidal
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator
D019468 Disease Management A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596) Disease Managements,Management, Disease,Managements, Disease

Related Publications

Dharani Kumari Narendra, and Dean R Hess, and Curtis N Sessler, and Habtamu M Belete, and Kalpalatha K Guntupalli, and Felix Khusid, and Charles Mark Carpati, and Mark Elton Astiz, and Suhail Raoof
April 1981, The American journal of cardiology,
Dharani Kumari Narendra, and Dean R Hess, and Curtis N Sessler, and Habtamu M Belete, and Kalpalatha K Guntupalli, and Felix Khusid, and Charles Mark Carpati, and Mark Elton Astiz, and Suhail Raoof
January 2015, Case reports in pediatrics,
Dharani Kumari Narendra, and Dean R Hess, and Curtis N Sessler, and Habtamu M Belete, and Kalpalatha K Guntupalli, and Felix Khusid, and Charles Mark Carpati, and Mark Elton Astiz, and Suhail Raoof
June 2021, The Journal of emergency medicine,
Dharani Kumari Narendra, and Dean R Hess, and Curtis N Sessler, and Habtamu M Belete, and Kalpalatha K Guntupalli, and Felix Khusid, and Charles Mark Carpati, and Mark Elton Astiz, and Suhail Raoof
June 2010, Chest,
Dharani Kumari Narendra, and Dean R Hess, and Curtis N Sessler, and Habtamu M Belete, and Kalpalatha K Guntupalli, and Felix Khusid, and Charles Mark Carpati, and Mark Elton Astiz, and Suhail Raoof
October 2019, Journal of bronchology & interventional pulmonology,
Dharani Kumari Narendra, and Dean R Hess, and Curtis N Sessler, and Habtamu M Belete, and Kalpalatha K Guntupalli, and Felix Khusid, and Charles Mark Carpati, and Mark Elton Astiz, and Suhail Raoof
May 2010, Chest,
Dharani Kumari Narendra, and Dean R Hess, and Curtis N Sessler, and Habtamu M Belete, and Kalpalatha K Guntupalli, and Felix Khusid, and Charles Mark Carpati, and Mark Elton Astiz, and Suhail Raoof
January 2004, Journal of intensive care medicine,
Dharani Kumari Narendra, and Dean R Hess, and Curtis N Sessler, and Habtamu M Belete, and Kalpalatha K Guntupalli, and Felix Khusid, and Charles Mark Carpati, and Mark Elton Astiz, and Suhail Raoof
December 2001, Pediatric pulmonology,
Dharani Kumari Narendra, and Dean R Hess, and Curtis N Sessler, and Habtamu M Belete, and Kalpalatha K Guntupalli, and Felix Khusid, and Charles Mark Carpati, and Mark Elton Astiz, and Suhail Raoof
January 2015, Gaceta medica de Mexico,
Dharani Kumari Narendra, and Dean R Hess, and Curtis N Sessler, and Habtamu M Belete, and Kalpalatha K Guntupalli, and Felix Khusid, and Charles Mark Carpati, and Mark Elton Astiz, and Suhail Raoof
December 2003, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!